Back to Search
CAMERON JOHNSTONE, MD
MD
Internal Medicine Physician
NPI: 1962909697IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
V3175(TX)21518(NV)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Education
OTHER
Class of 2018
Research & Publications (20)
Valuing river characteristics using combined site choice and participation travel cost models.
PMID 16380206·J Environ Manage·2006
8-other
Making medicinal chemistry more effective--application of Lean Sigma to improve processes, speed and quality.
PMID 19508922·Drug Discov Today·2009
6-review
Low frequency of MLL3 mutations in colorectal carcinoma.
PMID 19215798·Cancer Genet Cytogenet·2009
4-observational
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
PMID 19074899·Cancer Res·2008
8-other
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
PMID 18458333·Proc Natl Acad Sci U S A·2008
8-other
Relevance of viral context and diversity of antigen-processing routes for respiratory syncytial virus cytotoxic T-lymphocyte epitopes.
PMID 18753229·J Gen Virol·2008
7-preclinical
Parvin-beta inhibits breast cancer tumorigenicity and promotes CDK9-mediated peroxisome proliferator-activated receptor gamma 1 phosphorylation.
PMID 17998334·Mol Cell Biol·2008
7-preclinical
IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms.
PMID 17457048·Cancer Biol Ther·2007
7-preclinical
Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.
PMID 17822406·Traffic·2007
6-review
The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.
PMID 17974918·Genes Dev·2007
7-preclinical
A quantitative assessment of hERG liability as a function of lipophilicity.
PMID 17239590·Bioorg Med Chem Lett·2007
8-other
Large-scale sequencing of the colorectal cancer genome unearths novel pathways to tumorigenesis and provides potential druggable targets for cancer therapy.
PMID 17383441·Gastroenterology·2007
8-other
TGF-betaRII rescues development of small intestinal epithelial cells in Elf3-deficient mice.
PMID 17408644·Gastroenterology·2007
7-preclinical
Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats.
PMID 16921397·Br J Pharmacol·2006
7-preclinical
Design of a potent, soluble glucokinase activator with excellent in vivo efficacy.
PMID 16503142·Bioorg Med Chem Lett·2006
8-other
N-cadherin and keratinocyte growth factor receptor mediate the functional interplay between Ki-RASG12V and p53V143A in promoting pancreatic cell migration, invasion, and tissue architecture disruption.
PMID 16705170·Mol Cell Biol·2006
7-preclinical
Evaluation of patellar tracking in symptomatic and asymptomatic individuals by magnetic resonance imaging.
PMID 15517249·Skeletal Radiol·2005
8-other
PRR5 encodes a conserved proline-rich protein predominant in kidney: analysis of genomic organization, expression, and mutation status in breast and colorectal carcinomas.
PMID 15718101·Genomics·2005
8-other
Discovery, synthesis and biological evaluation of novel glucokinase activators.
PMID 15808477·Bioorg Med Chem Lett·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 6355 S BUFFALO DR
LAS VEGAS, NV 89113 - Phone
- (702) 952-9171
Quick Facts
- NPI
- 1962909697
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile